Cofactor Genomics Announces Clinical Validation of its Tumor Immune-Profiling Assay, ImmunoPrismTM
02 oct. 2018 08h00 HE
|
Cofactor Genomics
CAP/CLIA validation of ImmunoPrismTM furthers Cofactor’s mission of leveraging RNA to build unique, transformative assays informing critical clinical decisions SAN FRANCISCO, Oct. 02, 2018 (GLOBE...